Breaking News: Zynex, Inc. Investors Encouraged to Join Securities Class Action Lawsuit
Los Angeles, CA – The Law Offices of Frank R. Cruz announces that investors who have incurred losses in Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) between November 1, 2022, and April 13, 2025, inclusive, are encouraged to join a securities class action lawsuit. The complaint alleges that Zynex and certain of its top executives violated the Securities Exchange Act of 1934 by making materially false and misleading statements and failing to disclose material information.
Background on Zynex, Inc.
Zynex is a Colorado-based medical technology company that designs, develops, manufactures, and markets non-invasive medical devices and neurostimulation technology for medical, industrial, and consumer markets. Its products include transcutaneous electrical nerve stimulation (TENS) devices, functional electrical stimulation (FES) systems, and other medical devices.
Alleged Misconduct
The lawsuit alleges that Zynex and its executives made false and misleading statements regarding the Company’s business, operations, and financial condition. Specifically, the complaint alleges that defendants failed to disclose that:
- Zynex’s sales growth was unsustainable;
- The Company’s revenue recognition practices were inadequate;
- The Company’s financial statements contained material misstatements;
- Zynex was experiencing declining sales and revenue;
- The Company’s financial condition was weaker than reported;
- The Company faced significant competition and regulatory challenges.
Impact on Individual Investors
If you invested in Zynex, Inc. between November 1, 2022, and April 13, 2025, you may be able to recover your losses through the securities fraud class action lawsuit. The Law Offices of Frank R. Cruz invites you to contact them to discuss your potential recovery. You may be entitled to compensation for your losses, which may include damages for the sale of shares below their true value, as well as any subsequent losses due to the decline in value of your shares.
Impact on the World
The securities fraud class action lawsuit against Zynex, Inc. could have significant implications for the medical technology industry as a whole. The allegations of inadequate revenue recognition practices and material misstatements in the Company’s financial statements could lead to increased scrutiny of other medical technology companies and their reporting practices. Additionally, the lawsuit could result in increased regulatory oversight and potential changes to reporting requirements for medical technology companies.
Conclusion
The Law Offices of Frank R. Cruz encourages investors who have suffered losses in Zynex, Inc. between November 1, 2022, and April 13, 2025, to contact them to discuss their potential recovery. The securities fraud class action lawsuit alleges that the Company and its executives made false and misleading statements regarding the Company’s business, operations, and financial condition, which could have significant implications for the medical technology industry as a whole. If you believe you may be entitled to compensation for your losses, do not hesitate to contact the Law Offices of Frank R. Cruz for a free consultation.
The Law Offices of Frank R. Cruz is a national firm with offices in California, New York, and Washington D.C. They focus on securities fraud, corporate governance, and consumer class actions. The firm has recovered over $1 billion for their clients.
